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Abstract 
Pulmonary surfactant is an endogenous material that lines and stabilises the alveolar air-liquid interface. 
Respiratory mechanics can be compromised by exposure to environmental toxins such as cigarette vapour, 
which contains nicotine.  This study aims to determine the influence of nicotine on the activity of simulated 
lung surfactant at pH 7 and pH 9.  In all cases, the addition of nicotine to the test zone caused deviation in 
surfactant film performance.  Importantly, the maximum surface pressure was reduced for each system.  
Computational modelling was applied to assess key interactions between each species, with the Gaussian 09 
software platform used to calculate electrostatic potential surfaces.  Modelling data confirmed either nicotine 
penetration into the two-dimensional structure or interfacial / electrostatic interactions across the underside.  
The results obtained from this study suggest that nicotine can impair the ability of pulmonary surfactant to 
reduce the surface tension term, which can increase the work of breathing.  When extrapolated to gross lung 
function alveolar collapse and respiratory disease (e.g. chronic airway obstruction) may result.  The delivery of 
nicotine to the (deep) lung can cause a deterioration in lung function and lead to reduced quality of life. 
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1. Introduction 
  
Pulmonary surfactant plays a critical role in the respiratory system.  This endogenous material 
preserves airway patency by adsorbing at the alveolar air-liquid interface and reducing the surface 
tension term to near zero values.  The substance is a complex, multicomponent mixture containing 
phospholipids along with specific protein molecules (i.e. SP-A, SP-B, SP-C and SP-D), which is 
secreted by type II epithelial cells located in the alveolar space [1].  Phospholipid molecules account 
for approximately 90% of the blend by weight and of these dipalmitoylphosphatidylcholine (DPPC) 
predominates [2]. Additional species include saturated and unsaturated phosphatidylglycerols (e.g. 
POPG), unsaturated phosphatidylcholine and anionic lipids.  Molecules such as cholesterol, 
triglycerides and fatty acids form the remainder of the material [3].  As a result of the inherent 
arrangement at the alveolar air-liquid interface, pulmonary surfactant is the point of first contact for 
any material inhaled from the external environment. 
 
DPPC is responsible for reducing the surface tension term to near zero values in the alveolar space.  
At 41°C DPPC displays a gel to liquid phase transition and as such the molecule exists in an ordered 
state at body temperature [4 & 5].  Here, there is capacity for the saturated fatty acyl chains to pack 
together closely with supportive electrostatic interactions between oppositely charged portions of 
the polar head groups [6].  As a result DPPC adsorbs very slowly at the air-liquid interface [5], which 
limits overall spreadability.  Thus, for the surfactant film to function effectively, additional species 
such as phosphatidylglycerols, cholesterol, unsaturated phospholipids and proteins are naturally 
incorporated within the blend.  The DPPC molecule is zwitterionic in nature and composed of two 
saturated, 16-carbon palmitic chains that are attached to a negatively charged phosphate group and 
ultimately a positively charged trimethylammonium moiety [7]; the molecular structure of the 
species is detailed in Figure 1a.  In addition to charge-charge interactions, the inherent chemistry 
enables the molecule to serve as both a C-H hydrogen bond donor (i.e. via the trimethylammonium 
group) and a hydrogen bond acceptor (via the phosphate oxygen atoms) [8].  Furthermore, both the 
charged phosphate and trimethylammonium groups may also have the capability of forming ionic 
bonds with suitably charged species in solution. 
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The POPG molecule is of anionic character and exhibits chemistries similar to DPPC [9].  This 
molecule increases the fluidity of the surfactant monolayer at the alveolar air-liquid interface and 
thereby enhances the respreading profile on inhalation [9].  This effect is achieved by increasing the 
two-dimensional ordering of the DPPC molecules plus the inherent molecular flexibility [10].  
Furthermore, both the attractive and repulsive intermolecular electrostatic forces and hydrogen 
bonding between zwitterionic DPPC and anionic POPG polar head groups supports optimal packing 
behaviour and thus surfactant function [6].  The key differences in chemical arrangement when 
compared to DPPC involve an unsaturated fatty acid chain attached to the charged phosphate group 
and the presence of a hydrocarbon chain attached to two hydroxyl groups in place of the 
trimethylammonium functionality [11].  The resulting chemistries enable POPG to function as either 
a hydrogen bond acceptor or donor when interacting with molecules dissolved in the supporting 
aqueous subphase [8].  In addition, each hydroxyl group holds the potential to form intermolecular 
bonds between neighbouring molecules or intramolecular bonds within one molecule [12].   
 
Palmitic acid is 16-membered, saturated fatty acid with a terminal carboxylic acid group; the 
molecular arrangement is presented in Figure 1c [1, 10 & 13].  This molecule is frequently included 
within commercially available surfactant replacement preparations (e.g. Survanta) to facilitate 
material respreading at the alveolar air-liquid interface [2].  Furthermore, the incorporation of 
palmitic acid into a surfactant monolayer increases viscosity and the strength of solid domains rich in 
DPPC [2, 13 & 14].  The ionised carboxylic acid functionality inherent within the molecule may serves 
as a hydrogen bond acceptor within aqueous media.  As such, the moiety is able to experience 
lateral electrostatic interactions and form charge-enhanced hydrogen bonds with the polar head 
groups of DPPC and POPG [15].   
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Figure 1. The molecular structures of (a) DPPC, (b) POPG and (c) PA. 
 
Langmuir monolayers composed of phospholipid molecules and surfactant-specific proteins may be 
applied within the research setting as models to mimic the alveolar air-liquid interface [16].  In an 
identical fashion to the lung, the amphiphilic molecules arrange themselves such that the fatty acyl 
chains are displaced away from the aqueous subphase while the polar head groups make direct 
contact [3].  Lateral forces may be applied to the monomolecular films in isolation or indeed quick 
succession to obtain expansion / compression cycles reflective of typical human breathing patterns 
[17].  Langmuir pressure-area (-A) isotherms may be applied to demonstrate the structure-function 
activity profile of amphiphilic material in response to challenge with active pharmaceutical 
ingredients or environmental toxins (i.e. nicotine). 
Tobacco vapour is composed of over 4000 compounds, containing toxic chemicals, irritants and over 
60 carcinogens [18].  It is estimated that the use of tobacco causes approximately 6 million deaths 
worldwide per annum and it is thus regarded as a significant public health concern [19].  Tobacco 
smoke may be classified as either mainstream smoke (i.e. that inhaled by the smoker) or 
environmental tobacco smoke (ETS) (i.e. the smoke emitted from a lit cigarette plus exhaled 
mainstream smoke).  As previously alluded to, upon inhalation of tobacco smoke pulmonary 
surfactant is the first point of contact for the range of compounds held within the aerosolised 
vapour [3].   
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Thus, the interaction between the major components (e.g. nicotine) and the molecular species 
forming the surfactant material is an important influence on gross lung function.  To this end, in 
2003 Bringezu and co-workers reported that after exposure to ETS surfactant, efficacy and stability 
was reduced.  Here, alterations in lipid composition and distribution were thought to influence 
surfactant respreading thus causing inadequate coverage at the air-liquid interface on expansion.  
The group proposed that impairments in pulmonary surfactant structure-function activity can 
compromise lung function [1]. 
Nicotine is a naturally occurring alkaloid that is both highly addictive and toxic [20].  The substance is 
one of many emitted from cigarettes upon use and accounts for approximately 0.5 - 2.0 mg by mass 
of each unit.  Typically, a total of 20% of nicotine inhaled by the consumer is rapidly absorbed into 
the bloodstream [21]  The net effect is the increase in central dopamine and noradrenaline levels 
that evoke an instant change in mood (i.e. provide feelings of pleasure, reduced stress and anxiety).  
The nicotine molecule (3-(1-methyl-2-pyrollidiniyl)-pyridine) is considered to be a weak organic base 
owing to the presence of two nitrogen atoms that function as proton-acceptor sites [22].  The 
species is composed of a 5-membered pyrrolidine ring of pKa 8.02 that contains its nitrogen atom in 
the more basic sp3 configuration and a 6-membered pyridine ring of pKa 3.12 in which the nitrogen 
atom is in the sp2 configuration [23].  Nicotine can exist as the cis- or trans- stereoisomer (with 
regards to the relative position of the pyridine and methyl groups) with interchange between the 
two being rapid; the molecular structure of the nicotine molecule is illustrated in Figure 2.   
 
 
 
 
Figure 2.  The chemical structure of nicotine. 
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Variation in the protonation state of this molecule is dependent on solution pH.  For example, below 
pH 3 the diprotonated species exists, between pH 4-7 the monoprotonated form presents (due to 
the protonation of N-methyl-pyrrolidine) and above pH 9 nicotine exists as a neutral molecule [22].  
Therefore at physiological pH, the predominant species are the singly protonated pyrrolidinium form 
and the neutral form [24].  Further to protonation of the nitrogen atoms, potential exists for the 
nicotine molecule to interact attractively with either the negatively charged functionalities within 
pulmonary surfactant (i.e. the negatively charged phosphate groups of DPPC and POPG) forming 
ionic bonds or indeed with the hydrogen bond donors (i.e. hydroxyl groups) resulting in ion-dipole 
interactions.  Repulsive electrostatic interactions with the positively charged ammonium groups may 
be a necessary consequence of the proximity required to form these attractive interactions. 
The surface electrostatic potentials for nicotine and the polar regions of DPPC, POPG and PA may be 
calculated via application of quantum mechanics, as exemplified by studies of halogen bonding and 
aromatic-π anion interactions [25 & 26].  Such information can lend support to further understand 
important molecular interactions between each species and how key functionalities orientate 
themselves when in close contact.  Density functional theory can provide electrostatics of sufficient 
accuracy to explain interactions [27].  This approach will be applied to rationalise information 
obtained from Langmuir monolayer studies such that deviations in the isotherms from the normal 
can be mechanistically explained. 
This study aims to probe the response of simulated pulmonary surfactant monolayers to the 
application of nicotine within aqueous environments at pH 7 and pH 9.  A molecular modelling 
approach will be applied to rationalise key trends within the data.  The results obtained will be 
extrapolated to the human respiratory system with potential implications to lung function 
considered. 
 
2. Materials and Methods 
 
2.1 Materials 
 
(-)-Nicotine of 98.5% purity was purchased as Pestanal® from Sigma-Aldrich, UK (BN: SZBD102XV).  
The surfactants DPPC (Avanti Polar Lipids, USA. BN: 160PC-315), POPG (Avanti Polar Lipids, USA. BN: 
160-181PG-131) and PA (Sigma-Aldrich, UK. BN: 087K1877) were of analytical grade and used as 
supplied.  Chloroform (CHCl3) of analytical grade (≥ 99.9%, VWR Chemicals, UK.  BN: 14B200510) was 
employed as the spreading solvent.   
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Ultrapure water (Purite, UK), demonstrating a resistivity of 18.MΩcm, was used both during cleaning 
procedures and as the aqueous subphase.  In order to achieve pH adjustment, appropriate volumes 
of sodium hydroxide (Fisher Scientific, Loughborough.  BN: 1557941) were added to the aqueous 
subphase.   
 
2.2 Method 
 
         2.2.1   Langmuir Monolayers 
 
 
Surfactant monolayers were produced using a Langmuir trough (Model 102M, Nima Technology, 
UK).  Surfactant-free Kimtech tissues (Kimtech Science, Kimberley-Clark Professional, 75512, UK) 
were soaked in chloroform and used to clean all the glassware and contacting surfaces. Test runs 
that monitor surface pressure during barrier compression were performed to ensure cleanliness. 
Cleanliness was considered to have been achieved when the surface pressure was below 0.4mNm-1 
at complete barrier compression, in the absence of a surfactant monolayer.   
A spreading solution composed of DPPC, POPG and PA in the ratio 69:20:11 was produced by 
dissolving the surfactant material in chloroform (1 mg ml-1).  In total 10µl of this solution was 
delivered to the surface of the pure water subphase by drop-wise addition using a Hamilton 
microsyringe and left for 10 minutes to facilitate chloroform evaporation and surfactant spreading. 
The trough barriers were programmed to move to the centre of the trough at a rate of 25 cm2 min-1.  
Plots of surface pressure vs. area per molecule for the surfactant system at ambient temperature 
(e.g. 20°C) were collected using a Wilhelmy plate at the centre of the compartment. 
 
2.2.2   Nicotine Administration to Simulated Pulmonary Surfactant Monolayers 
 
Initially, a total of 10μl of the nicotine stock solution was taken and diluted to 10ml with ultrapure 
water to provide a 1mg/ml aqueous solution.  A volume of either 100μl or 200μl of the diluted 
nicotine solution was injected underneath the simulated pulmonary surfactant monolayer via a 
Hamilton microsyringe at full film expansion in order to monitor dose-response effects.  
Subsequently, a period of 10 minutes was given to allow for nicotine-monolayer interaction and 
corresponding Langmuir isotherms / isocycles were then obtained for each system under 
investigation. 
8 | P a g e  
 
2.2.3 Control over System pH 
 
Consideration was afforded to the interaction between nicotine and simulated pulmonary surfactant 
monolayers at pH 7 and 9.  The pH of the subphase was adjusted by use of sodium hydroxide.  The 
pH 7 system was readily established via collection of water from the purification platform.  To 
achieve a subphase at pH 9, a total of 6μl of 0.2M sodium hydroxide was added to 60ml ultrapure 
water via a Gilson pipette and the resulting solution thoroughly mixed.  The pH of all aqueous 
solutions was monitored by a digital pH meter (HANNA Instruments, pH211 Microprocessor pH 
Meter).  In all cases three replicates at each pH were undertaken to ensure consistency of results.  
Each experiment was conducted over a relatively short timescale (e.g. 10 minutes as a maximum).  
Consequently, there would have been limited opportunity for significant amounts of atmospheric 
CO2 to dissolve across the 70cm
2 surface and into the supporting subphase.  As such, environmental 
impact on system pH was minimal. 
 
2.2.4 Langmuir Monolayer Analysis 
 
2.2.4.1 Compressibility 
 
To enable the assessment of the competence of a surfactant to reduce the surface tension with 
minimal changes to surface area [28], the compressibility term was calculated.  Lung surfactant 
should ideally have a low compressibility value, which translates in vivo to gas exchange taking place 
over a larger surface area [28 & 29].  The lower the compressibility term, the more rigid the 
surfactant film is (i.e. the material is of low elasticity), with the opposite being true [30 & 31].  The 
formula used to obtain compressibility values for each surfactant system is provided in Equation 1. 
 
Compressibility = 
1
𝐴
𝑥
1
𝑚
 
 
Equation 1. Calculation of the compressibility of the monolayer. 
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Where A represents the relative surface area and m the slope of the isotherm. Here, ‘m’ was 
calculated using ‘m = 
𝑦2−𝑦1
𝑥2−𝑥1
’ over the range of 30-10mN/m surface pressure, whereby ‘y’ and ‘x’ 
values characterise surface pressure and area values, respectively. The area values were converted 
from angstroms squared per molecule (A2/molecule) to percentage trough area for this calculation 
to be conducted [28].   
 
2.2.4.2 Limiting area-per-molecule 
 
The limiting area (Alim), or the area in the most condensed region of the monolayer, represents the 
cross-sectional area of the molecule in the monolayer and was obtained by extrapolating the linear 
liquid expanded-liquid condensed slope of the π-A isotherm to π = 0 [32 & 33]. This parameter offers 
an insight into the molecular state within the monolayer, more specifically revealing whether the 
molecules are more condensed or expanded [32 & 33].  A higher value signifies loose molecular 
arrangement within the monolayer over a larger area, and thus represents an expansion. Whereas, a 
lower value indicates that a lower area is available to lipid molecules, resulting in a tightly-packed, 
condensed monolayer [34]. 
 
2.2.4.3 Lift-off area 
 
Lift-off area represents the point at which the surface pressure of the compression isotherm starts 
to rise from the baseline, it was determined by extrapolating this point to the horizontal ‘area’ axis 
of the surface pressure-area isotherm [28]. Lift-off area characterizes the molecular interactions and 
packing within the monolayer, providing a second numerical figure capable of reinforcing the 
‘limiting area-per-molecule’ outcome, to further evidence molecular expansion or compression. 
Here, again, larger values indicate a more expanded state, whereby molecules are occupying a larger 
space with reduced intermolecular interactions, and vice versa [30]. 
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2.2.4.4 Area under the curve and hysteresis of isotherms 
 
To further determine the compressibility of the monolayer, the area under the curve (AUC) term was 
calculated via Equation 2, namely the ‘Trapezoid Rule’. 
 
(𝐴1 − 𝐴2) 𝑥
 (𝑃1 + 𝑃2) 
2
 
 
Equation 2. Calculation of the AUC term. 
 
Where A represents relative Langmuir trough area values (i.e. taken directly from the x axis) and P is 
the corresponding surface pressure term (i.e. taken directly from the y axis) at the given area. This 
calculation was undertaken throughout the whole isotherm area of 82-25mN/m at 5mN/m intervals, 
these values were successively totalled to provide the final AUC.  The hysteresis area, a parameter 
that has restricted use to cyclic isotherms, was formulated as the difference between the area under 
the curve of compression and expansion [28].  The hysteresis area represents the variance between 
the free energy of compression and free energy of expansion. 
 
2.2.4.5 Statistical Analysis 
 
All compression isotherms were carried out at least three times to ensure reproducibility, and 
compression-expansion cycles were conducted as duplicates. The standard deviation was calculated 
to produce standard error bars of the mean, which was calculated via Equation 3. 
 
𝑆𝐸𝑥 =  
𝑠
√𝑛
 
 
Equation 3. Calculation of standard error of the mean. 
 
Where s is the sample standard deviation and n is the size (number of observations) of the sample. 
Significant differences can be visualised using these standard error bars of the mean; when the error 
bars of different isotherms do not intersect, this provides clear evidence that there is no overlap of 
data and ultimately, that meaningfully different values are existent. 
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2.2.5 Molecular Modelling 
 
 
To visualise and rationalise the interactions between nicotine and key components of the simulated 
pulmonary surfactant monolayer (i.e. DPPC, POPG and PA) the structures were studied at the RHF/6-
31G* level using the Gaussian09 suite of programs [35, 36, 37 & 38].  Conformations of the key 
elements for molecular recognition (excluding the long hydrocarbon chains) were generated using 
omega [39].  After geometry optimisation, the electron density was visualised in Gaussview [40]. The 
electrostatic potential is projected onto a surface of constant electron density using default values 
within the program.  Representations of the projected electrostatic potential were generated from 
two opposing sides. The protocol led to the generation of a number of images that represent all of 
the entities that could potentially interact at the test interface.   
 
3 Results and Discussion 
 
 
During this study, stable mixed surfactant films comprising DPPC, POPG and PA were established to 
mimic the endogenous material located at the alveolar air-liquid interface within the (deep) lung.  As 
such, on compression and expansion those interactions taking place across the two-dimensional 
plane were reflective of those associations taking place during normal lung function within the body 
[41].   
 
3.1 Baseline: Langmuir Isotherms at pH 7 and 9 
 
Langmuir pressure-area isotherms of monolayers composed of DPPC, POPG and PA on an ultrapure 
water subphase at pH 7 or pH 9 are presented in Figure 3.  
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Figure 3. Langmuir π-A isotherms for the DPPC: POPG: PA system on a subphase of water at pH 7 and 9. The 
data are determined from a total of 3 repeats, with error bars displaying the standard error of the mean.  
Temperature: 201
o
C. 
 
In both cases, it is evident that as the mixed monolayer is compressed there is a rise in surface 
pressure producing a smooth curve with gradient changes indicative of phase transitions within the 
surfactant film [42].  The mixed system at both pH values reaches an identical maximum surface 
pressure of 60mN/m.  Furthermore, the lift-off area is similar between each system, and 
instantaneous at 80A2/molecule.  However, differences do arise when consideration is given to 
parameters such as the AUC, which is the largest for pH 9 (i.e. 100% at pH 9 and 86% at pH 7).  The 
data signify that the molecules are in a more expanded state at pH 9.  This observation is 
corroborated by the limiting area-per-molecule (Alim) values of 72A
2/molecule for pH 9 and 
59A2/molecule for pH 7.   
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3.2 Nicotine Administration 
 
 
3.2.1 Nicotine – Simulated Pulmonary Surfactant Monolayer Interaction at pH 7 
 
Langmuir pressure-area isotherms of the mixed surfactant systems were acquired at pH 7 in the 
absence and presence of nicotine, the results obtained are illustrated in Figure 4.  
 
 
Figure 4. Average compression isotherms (n=3) for the simulated monolayer system supported on a pH 7 
subphase before and after nicotine addition.  Temperature: 201
o
C. 
 
The addition of 100µl and 200µl of nicotine to the underside of the mixed surfactant monolayer 
lowered the maximum surface pressure from 60mN/m to 52mN/m.  In addition, the AUC decreased 
from 100% to 97.4% (100µl nicotine) and 95.4% (200µl nicotine).  On inspection of the data 
presented in Figure 4, the Langmuir isotherm acquired on the nicotine-containing subphases 
demonstrate a deviation to the right at low surface pressures, implying that the monolayer exhibits 
an expanded character. This point is further supported by Alim values, which increase from 
60A2/molecule (pH 7), to 67A2/molecule (100µl and 200µl nicotine).  Compressibility values of 
0.0122mN/m were observed following addition of both volumes of nicotine, in comparison to a 
baseline value of 0.0115mN/m, which equates to a 6% increase in the parameter.  The data confirm 
that there is no significant difference in effect when 100µl or 200µl of nicotine are delivered to the 
underside of the mixed surfactant monolayer at pH 7.  This confirms that in the case of the lower 
concentration of nicotine, the surfactant film is saturated with the molecules in solution. 
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3.2.2 Nicotine – Simulated Pulmonary Surfactant Monolayer Interaction at pH 9 
 
Langmuir pressure-area isotherms of the mixed surfactant systems were acquired at pH 9 in the 
presence and absence of nicotine, the results obtained are detailed in Figure 5.  
 
Figure 5. Average compression isotherms (n=3) for the simulated monolayer system supported on a pH 9 
subphase before and after nicotine addition.  Temperature: 201
o
C. 
 
The delivery of nicotine to the aqueous subphase induces clear changes to the Langmuir isotherms 
at pH 9.  There is a clear reduction in maximum surface pressure, from 60mN/m (pH 9 alone) to 
52mN/m following the addition of 100µl or 200µl of nicotine solution.  In this case, there is a strong 
dose-response translocation of the curves to the left side.  The AUC reduces substantially more at pH 
9 than at pH 7 on nicotine addiction and in a clear dose-response fashion from 100% to 83% and 
76%. This trend is also confirmed via the compressibility values, rising from 0.0105mN/m (pH 9 
alone) to 0.0127mN/M and 0.0130mN/M (pH 9 with 100µl and 200µl addition, respectively); 
equating to a 24% increase.  As such, the film becomes less rigid and more compressible.  The Alim 
term corroborates this finding as it decreases from 72A2 /molecule to 64A2/molecule (100µl nicotine) 
and 61A2/molecule (200µl nicotine), clearly moving towards lower area per molecule. 
On delivery of nicotine to the underside of the simulated pulmonary surfactant film, deviation in 
surfactant activity was evident irrespective of solution pH.  The ionisation state of the nicotine 
molecule is an important factor to consider when attempting to rationalise the study findings.  This 
is so because the charge distribution within the nicotine molecule will govern how the entity will 
interact with the neighbouring surfactant film.   
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Following protonation, the nitrogen atom in the pyrrolidine ring becomes positively charged [43].  
Whilst the components of the model surfactant film applied herein are at a constant charge 
between pH 6 to 11.  Within this pH range, the DPPC molecule exists as a zwitterion and the POPG 
and PA molecules demonstrate overall anionic character [43].  Accordingly, the molecular potential 
of each component within the systems of interest can be applied to explain key mechanisms of 
interaction.  On addition of nicotine to an ultrapure water subphase at pH 7, the simulated 
pulmonary surfactant monolayer demonstrates expanded character.  Here, the protonated nitrogen 
atoms within the nicotine structure (i.e. located on the pyrrolidine ring) bind to the negatively 
charged moieties within the monolayer structure via electrostatic interactions.  The nature of 
interaction facilitates the ready insertion of the nicotine molecule into the two-dimensional 
ensemble and as such the spatial arrangement is modified, leading to a change in molecular packing 
along the two-dimensional plane.  The net effect is a weakening of the intermolecular forces (e.g. 
van der Waals interactions) between each molecule forming the monolayer.  Such interactions cause 
disruption and expansion to the monolayer [44], which consequently increases the pressure 
required to compress the ensemble (i.e. an elevation in compressibility was noted of 6%).  
 
In the case of pH 9, the Langmuir isotherm and isocycles experience a translocation to the left side.  
This clear trend confirms condensed character, meaning that each molecule within the ensemble 
occupies a smaller area within that available on the surface.  As nicotine is basic in nature, it is to be 
expected that at alkaline pH the molecule will exist predominantly in the neutral form.  At pH 9, 
there is a greater proportion of non-protonated nicotine as compared to protonated nicotine within 
the aqueous environment [43].  The region of negative potential in the neutral form can interact 
with the positively charged end of the DPPC molecules and provide shielding of this positive charge 
which would reduce electrostatic repulsion with adjacent DPPC molecules.  Hence, there is scope for 
the nicotine molecules to bind, in the main, with the DPPC molecules and consequently condense 
the monolayer [44].   
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3.2.3 Langmuir Isocycles at pH 7 and pH 9 with and without Nicotine Addition 
 
Average Langmuir compression-expansion cycles of the mixed surfactant film located on an 
ultrapure water subphase at pH 7 before and after addition of 100 µl nicotine solution are presented 
in Figure 6.  The data presented are averages of eight consecutive compression-expansion cycles, to 
allow for confidence in the differences observed. 
 
Figure 6. Averaged π-A compression-expansion cyclic isotherms (n=3) for the mixed surfactant system on an 
ultrapure water subphase at pH 7, before and after 100µl nicotine administration. Temperature: 201
o
C. 
 
Upon inspection, a reduction in maximum surface pressure for the mixed surfactant monolayer 
when located on a nicotine containing subphase is apparent (e.g. a decline from 50mN/m to 
42mN/m on surfactant films initially pre-conditioned to the equilibrium point via 4 compression-
relaxation cycles).  The data are consistent with that presented in Figure 4.  In addition, the lift-off 
area value was greater when nicotine was applied to the underside of the surfactant film, being 
approximately 70 A2/molecule as compared to 62A2/molecule with the pure-water subphase.   
Moreover, the AUC reduced from 100% to 95.9% on nicotine addition plus the compressibility of the 
film increased from 0.00902mN/m to 0.0110mN/m (i.e. a 23% increase, demonstrating reduced 
rigidity and enhanced flexibility).  The hysteresis area of the isotherms (i.e. the area between 
compression and expansion) decreased on nicotine administration by 29mN/m.   
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Average Langmuir compression-expansion cycles of the mixed surfactant film located on an 
ultrapure water subphase at pH 9 before and after addition of 100µl nicotine solution are presented 
in Figure 7.  Again, the data are averages of eight consecutive compression-expansion cycles after a 
period of material pre-conditioning to the equilibrium point (e.g. a total of four compression-
relaxation cycles at the beginning of the experiment). 
 
 
 
Figure 7.  Averaged Langmuir π-A compression-expansion cyclic isotherms (n=3) for the mixed surfactant 
system on an ultrapure water subphase at pH 9, before and after 100µl nicotine administration. Temperature: 
201
o
C. 
 
The data confirm that upon nicotine addition to the underside of the mixed surfactant film at pH 9, 
clear interaction between each species takes place.  There is a notable reduction in maximum 
surface pressure from 53 mN/m to 44 mN/m along with movement of the curve to the left side.  In 
addition, the lift-off area reduces from 68 A2/molecule to 60 A2/molecule, again the data set reflects 
that presented in Figure 5.  Further to this, there is a significant reduction in the AUC term from 
100% to 78.6% and an increase in the compressibility value by 24%, suggesting enhanced flexibility 
across the plane.  Moreover, the hysteresis area of the isotherms presented shows a significant 
difference from pH 7, with a value of reduction of 80mN/m.  
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When considering the dynamic compression – expansion cycles at pH 7 and pH 9, the addition of 
nicotine to each system results in similar trends to single Langmuir isotherms.  In the case of pH 7, 
there is an initial monolayer expansion and a decrease in the maximum surface pressure attained.  
Whereas, at pH 9 the system demonstrates initial condensation with a reduced maximum surface 
pressure.  In both cases, the simulated pulmonary surfactant monolayer is capable of fulfilling its 
primary function of reducing the surface tension term (i.e. structure-function activity is not lost), 
which is clearly important for efficient lung mechanics.  Notwithstanding this point, the presented 
data do confirm that the systems would have become more condensed over time with the POPG 
molecule being effectively ‘squeezed out’ of the two-dimensional plane [2].  In this case, the 
surfactant film would exhibit increased rigidity due to loss / reduction of the key fluidiser molecule.  
A similar trend was documented by Bringezu and co-workers in 2003, where a simulated pulmonary 
surfactant monolayer of the same composition became condensed and demonstrated lower 
maximum surface pressure on repeated expansion-compression cycles [1].  The effective ‘loss’ of the 
fluidiser into the surface associated reservoir highlights the requirement for regular replenishment 
of the components forming pulmonary surfactant otherwise the surface tension term would remain 
high and this would consequently increase the work of breathing. 
 
3.3 Molecular Modelling 
 
3.3.1 Nicotine Interaction with Surfactant Film Components at pH 7 
 
The electrostatic potential surfaces (EPSs) of the polar head groups associated with each surfactant 
molecule under investigation plus the whole nicotine molecule were calculated via the quantum 
mechanics software package Gaussian09, as previously described.  Variable colour presentation 
symbolises differences in charge distribution across each functionality; where red indicates strongly 
negative regions, yellow less negative regions, blue strongly positive regions and cyan less positive 
regions.  Regions coloured green have an approximately neutral electrostatic potential. In addition, 
we have inserted arrows to highlight important regions of interaction between the particular 
sections of the molecules under consideration.   
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The EPSs presented in Figure 8 represent nicotine in its pyrrolidine-protonated state alongside the 
polar head regions of DPPC and POPG.  At pH 7, the nicotine molecule is predominantly (i.e. 60%) in 
this mono-protonated state [22 & 23].  The positively charged region within the nicotine molecule 
(i.e. blue region) will interact favourably with the negatively charged moieties within each of the 
amphiphilic molecules within the mixed surfactant film. 
                    
 
 
Figure 8.  EPS of calculation for the predominant phospholipid species within the mixed surfactant monolayer:  
a) DPPC and b) POPG.  The head groups are displayed on the right and left side of the protonated nicotine 
molecule located in the middle present at pH 7.  NB: Only the polar head groups are represented here.  The 
hydrophobic tail functionalities (not included in the calculation) would extend up and away from the normal of 
the air-liquid interface.  
 
The DPPC and POPG molecules contain their negatively charged phosphate moieties within the head 
groups and thus are located further into the membrane (i.e. closer to the alveolar air-liquid 
interface).  In this case, we suggest that the nicotine molecule must penetrate into the monolayer 
structure to permit interaction.  Such penetration into the monolayer structure will most likely occur 
at low surface pressures whilst the monolayer is expanded in the gaseous phase.   
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The open positioning of the molecules will facilitate nicotine entry into the two-dimensional 
ensemble.  Therefore, if the nicotine molecule is physically inserted between the head groups of 
DPPC and POPG the surfactant film should have a reduced ability to fully compress and the 
monolayer would exhibit an expanded character.  Here, the interaction is predominantly based upon 
electrostatic associations.  Indeed, this finding is consistent with the work conducted by Khattari and 
co-workers in 2011 [30].   This group applied a cationic surfactant to methyl octadecanoate (MO) 
monolayers and noted a deviation within the experimental data; larger molecular areas were found.  
The study established that the cationic surfactant became integrated into the monolayer structure.  
As anticipated, at higher surface pressures the monolayer is in a more condensed state.  Here, the 
lipid fractions experience hydrophobic interactions between the acyl chains to a greater extent.  At 
this point in the compression – expansion cycle, the interactions are indeed strong enough to 
prevent the further penetration of nicotine molecules.  This principle has been demonstrated by 
Silva and Romao [45] along with Grancelli and co-workers [46] who detailed that such compaction 
does not permit molecular species within solution to insert themselves amongst amphiphilic head 
groups.  Therefore, we propose that at high surface pressures, the neutral regions of DPPC and 
nicotine at pH 7 associate by hydrophobic interactions and force DPPC out of its usual plane, 
resulting in impairment of the surface tension lowering capability. 
 
3.3.2 Nicotine Interaction with Surfactant Film Components at pH 9 
 
Within aqueous media at pH 9 the nicotine molecule is primarily (90%) in the neutral form [22].  
Under such conditions, the lone pair on the nitrogen atom of the pyridine ring presents a compact 
region of negative potential.  This charge distribution is presented as the red region in the EPS 
calculation, with the remainder of the molecule being neutral, as illustrated in Figure 9. 
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Figure 9. EPS of DPPC (right and left) and neutral nicotine (middle) at pH 9. 
 
The in-silico data indicate that the pyridine ring within the nicotine molecule can interact with the 
positive charge held within the DPPC polar head group (i.e. the charged trimethylammonium group 
(blue)).  Here, nicotine is able to interact with DPPC molecules without necessitating penetration of 
the monolayer during expansion, hence the interaction may persist during all stages of compression-
expansion. These interactions explain the consistent shift to the left of the isotherms, signifying a 
transformation to lower area per molecule and the formation of a more condensed monolayer.  The 
location of this grouping close to the air-liquid interface renders nicotine capable of interacting at 
the interfacial regions, without having to penetrate into the monolayer to any great depth.  
Consequently, a reconfiguration of the lipid arrangement occurs with the DPPC molecules held 
closer together.   
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3.3.3 Nicotine interaction with components of the surfactant to reduce the surface pressure 
 
With reference to all Langmuir isotherm and isocycle data presented within this study, there is a 
clear reduction in the surfactant surface pressure term following nicotine administration to the 
supporting aqueous media.  This trend may be rationalised by reference to the EPS calculation 
detailed in Figure 10.   
 
 
Figure 10. EPS calculation of the polar head groups of DPPC (right and left) and neutral nicotine (middle). 
 
At pH 7, nicotine is approximately 40% in the neutral form and its surface is substantially neutral.  
Neutral regions are similarly noted in the DPPC molecules; specifically in the region of the two CH2 
groupings between the phosphate moiety and the charged trimethylammonium group.  
Consequently, these two uncharged zones can interact with each other via hydrophobic 
associations.  As such, when nicotine is located between two phospholipid head groups it can 
undergo electrostatic interactions with the positive charge on one of the DPPC molecules and 
hydrophobic interactions with the other DPPC molecule.  This interaction requires the DPPC 
molecules to slide out of alignment and would result in a shearing effect between the molecules. 
Ultimately, this can facilitate the buckle and collapse of the monolayer at higher surface pressures 
and hence a reduced maximum surface pressure term (π).  Furthermore, due to the DPPC molecules 
being outside of the normal plane the surfactant molecules have reduced contact with the aqueous 
media, which subsequently hinders the capacity to reduce the surface tension term.   
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Because the DPPC molecule presents as the largest lipid fraction within the model blend used in this 
study, it is reasonable to assume that the interaction between that component and nicotine is 
primarily responsible for the reduction in the maximum observed surface pressure.  This point is 
strengthened if we consider DPPC as the main ‘stabiliser’ molecule within the ensemble [47].  Here, 
the main function is to keep the monolayer rigid enough to attain near-zero surface tensions during 
exhalation.  Thus, if the bulk of the DPPC molecules are interacting with, and consequently being 
disrupted by nicotine molecules, scope to perform the stabilisation role is limited. 
During this work we have considered each interaction individually.  However, the array of 
interactions throughout the surfactant film will be the result of interaction of the nicotine molecules 
with a number of surrounding molecules, each of which we would expect to maximise its attractive 
interactions or else avoid coming into contact with the drug (i.e. by diffusing across the membrane) 
in cases where no attractive interactions are possible.   
 
3.4 Public Health 
 
The use of cigarettes / e-cigarettes is a common practice within developed countries such as the 
United Kingdom and the United States of America.  Despite the attempts made by various 
government and health agencies to educate the population and minimize exposure to tobacco 
smoke, thousands of individuals experience long-term respiratory diseases that impact upon health, 
wellbeing and quality of life.  By demonstrating the undesirable effects of nicotine on the molecular 
level, extrapolation of laboratory and in silico data can be used to highlight potential negative 
implications to the human body.   
The delivery of nicotine to the underside of simulated pulmonary surfactant caused a reduction in 
the surface pressure term in all cases. The data confirm that the ability of the surfactant film to 
reduce the surface tension was impaired, which would in turn result in an increased work of 
breathing.  The situation may give rise to respiratory distress syndrome, which can affect neonates 
and adults.  The disorder further results in impaired gas exchange, atelectasis (collapse or 
incomplete inflation of the lung), hypoxia, oedema, pulmonary hypertension and other associated 
complications [48 & 49].  Over time, such impairment to lung function can cause severe respiratory 
disorders including oedema and inflammation.  Clearly, these conditions can further impair the 
surfactant system and lead to a reduction in the quality of life [1 & 50].   
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Moreover, the increase in surface compressibility in nicotine’s presence corresponds to a smaller 
change in surface tension compared to surface area, and physiologically this translates to a decrease 
in the range of alveolar volumes over which surface tension contributes to alveolar stability [29].  
Related disease presentation may include; respiratory distress syndrome, obstructive lung disease 
(COPD, asthma, bronchiolitis) and interstitial lung disease; all are linked by their comparable 
pathogenesis [49]. Interstitial lung diseases can be described as restrictive ventilator defects, which 
are related to restricted lung expansion, decreased lung volume and an increased work of breathing 
[51]. 
 
4. Conclusion  
 
This study has clearly demonstrated that the addition of nicotine to an aqueous environment 
supporting a simulated pulmonary surfactant monolayer does cause modification to the activity 
profile of the amphiphilic material.  All experiments were conducted in model conditions (i.e. 
ultrapure water instead of salts, no surfactant proteins and spread monolayer without subphase 
reservoirs of surfactant material), however clear trends in the data are apparent and enable 
appropriate rationalisation and extrapolation to the human respiratory system.  Of the data 
collected, the pH 7 series is the most physiologically relevant as it reflects the value of the biological 
media within the lung.  The data confirm that the addition of nicotine expands the monolayer and 
impairs the ability to reduce the surface tension term; modelling data have provided a mechanistic 
explanation for this. 
This work provides a unique insight into how nicotine, the predominant molecule within cigarette 
vapour, can potentially influence lung function.  The interaction between each species may 
contribute to a number of disease states and cause the individual to experience breathlessness after 
smoking along with an increased respiratory rate to provide the body with adequate oxygen levels.  
Longer term consequences can involve the presentation of COPD and interstitial lung diseases.   
The combination of Langmuir monolayer technology with modelling techniques has provided a 
strong platform by which to better understand the interaction between the nicotine molecular and 
material presenting at the alveolar air-liquid interface.   Expansion of this work could involve further 
investigation relating to how other components of cigarette / e-cigarette vapour may influence 
surfactant function, typical examples for consideration include formaldehyde and ammonia.   
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